Olink Explorer >5400
- Response deadline
- Jul 25, 2026 Closed
- Date posted
- Jul 15, 2026
- Source
- Open notice
Description
Requirements: 2.0 BACKGROUND Our lab studies the role of inflammation/innate resistance and commensal microbiota in carcinogenesis, cancer progression and therapy of cancer. The following product features/characteristics are required for this requirement: Protein Coverage - Measures ~5,400+ human proteins simultaneously in a single workflow. Technology - Uses Proximity Extension Assay (PEA) with dual antibody recognition coupled to DNA barcoding and next-generation sequencing (NGS) readout. Sample input – requires only 2 ul of plasma, serum, and other sample types Specificity - Reported 99.5% specificity with negligible cross-reactivity due to dual-recognition antibody design. Dynamic Range - Approximately 10 orders of magnitude (fg/mL to mg/mL), enabling detection of both low- and high-abundance proteins. Key strengths Very broad proteome coverage while maintaining antibody-based specificity. Excellent sensitivity for low-abundance circulating proteins (especially cytokines and signaling proteins). Extremely low sample-volume requirement. Highly standardized platform, making it attractive for epidemiology and multi-omics studies.
Classifications
Documents (1)
- Requirement 7.docx.docx17 KBNot yet available
Contacts
Similar contracts
- Combines Synopsis Solicitation- NULISAseq InflammaDue Sep 11, 2026
- VHA Black Hills Health Care System Dialysis/SPS Water Testing VOSB Set-AsideSouth DakotaDue Sep 7, 2026
- Puget Sound VAHCS Water Management Program ServicesWashingtonDue Sep 19, 2026
- Inspection and Aerial Device Non-Destructive Test on Three Ladder Fire TrucksOkinawaDue Sep 10, 2026
- Sole Source- Underwater Blast Sensor Mapping SystemMarylandDue Sep 7, 2026
- FCI Three Rivers - Wastewater Sampling and Laboratory Analysis ServicesTexasDue Sep 10, 2026